Clinical risk factors for recurrence of pelvic organ prolapse after primary native tissue prolapse repair.


Journal

Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 08 04 2020
accepted: 22 03 2021
pubmed: 1 5 2021
medline: 8 2 2022
entrez: 30 4 2021
Statut: ppublish

Résumé

To define potential risk factors for recurrence of prolapse. This short report included all women who presented with recurrence of prolapse as well as without any recurrence signs after a vaginal approach of native tissue prolapse repair at an urogynecological center in Austria. A total of 124 recurrence cases and 64 women with no signs of recurrence after their index prolapse surgery were included. Multivariate analysis identified advanced preoperative POP‑Q stage (pelvic organ prolapse-quantification) as an independent risk factor for postoperative recurrence of prolapse (p = 0.045). Initial proper preoperative counseling is of particular importance to modulate patients' expectations after prolapse surgery.

Identifiants

pubmed: 33929606
doi: 10.1007/s00508-021-01861-8
pii: 10.1007/s00508-021-01861-8
pmc: PMC8813732
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-75

Informations de copyright

© 2021. The Author(s).

Références

Obstet Gynecol. 1997 Apr;89(4):501-6
pubmed: 9083302
Int J Surg. 2015 Aug;20:75-9
pubmed: 26079498
Int Urogynecol J. 2016 Nov;27(11):1619-1632
pubmed: 27379891
Obstet Gynecol. 2018 Aug;132(2):298-309
pubmed: 29995735
Int Urogynecol J. 2016 Feb;27(2):165-94
pubmed: 26755051

Auteurs

Barbara Bodner-Adler (B)

Department of General Gynecology and Gynecologic Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. barbara.bodner-adler@meduniwien.ac.at.
Department of Special Gynecology and Obstetrics, Karl Landsteiner Institute, Vienna, Austria. barbara.bodner-adler@meduniwien.ac.at.

Klaus Bodner (K)

Department of General Gynecology and Gynecologic Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Greta Carlin (G)

Department of General Gynecology and Gynecologic Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Oliver Kimberger (O)

Department of Anesthesiology, Medical University of Vienna, Vienna, Austria.

Julian Marschalek (J)

Department of Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria.

Heinz Koelbl (H)

Department of General Gynecology and Gynecologic Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Wolfgang Umek (W)

Department of General Gynecology and Gynecologic Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH